← Back to Search

Other

Treatment Group (Hand Sanitizer) for Viruses

Phase < 1
Recruiting
Research Sponsored by Leciel Bono
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-14 days
Awards & highlights

Study Summary

This trial will test if using Purell hand sanitizer can reduce the size, pain, and discomfort of HSV-1 (herpes) lesions and shorten their duration.

Eligible Conditions
  • Herpes
  • Viruses
  • Herpes Simplex Virus
  • Cold Sores

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of HSV-1 Lesion
Secondary outcome measures
Level of Discomfort during Treatment
Level of Pain during Treatment
Size of Lesion during Treatment

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Treatment Group (Hand Sanitizer)Experimental Treatment1 Intervention
Participants with an early prodromal stage of an HSV-1 outbreak (less than 24 hours from initial symptom), with the visible manifestation of a lesion will be invited to participate in the study. Participants will apply a large drop of hand sanitizer in an unmarked container to a Q-tip and will hold the Q-tip on the lesion for 10 seconds. The hand sanitizer will be administered every waking hour in the same manner.
Group II: Control Group (Medical Grade Mineral Oil)Placebo Group1 Intervention
Participants with an early prodromal stage of an HSV-1 outbreak (less than 24 hours from initial symptom), with the visible manifestation of a lesion will be invited to participate in the study. Participants will apply a large drop of Medical Grade Mineral Oil in an unmarked container to a Q-tip and will hold the Q-tip on the HSV-1 lesion for 10 seconds. The medical grade mineral oil will be administered every waking hour in the same manner.

Find a Location

Who is running the clinical trial?

Leciel BonoLead Sponsor
Leciel Bono, MSStudy ChairIdaho State University
~6 spots leftby Jun 2025